Android app Apple app link

Acclaro Medical secures $23m in Series B funding for skin laser technologies

By Yahoo! Finance   |   3 weeks ago
Acclaro Medical secures $23m in Series B funding for skin laser technologies

Acclaro Medical raises $23m in Series B funding led by Accelmed Partners to support the growth of UltraClear and AuraLux products, aiming for global expansion. The FDA-cleared UltraClear laser offers advanced skin resurfacing with enhanced safety features.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.